Therapeutic Innovation Australia is a national consortium of translational research infrastructure. 
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.
2021 National Research Infrastructure Roadmap is now live! 

What research infrastructure will enable Australia to maintain its research excellence, increase innovation and address emerging research challenges?
 
NCRIS PROVIDER_CMYK_LG.jpg